A "Post-mortem" of COVID-19-associated stroke: a case-control study

J Stroke Cerebrovasc Dis. 2022 Nov;31(11):106716. doi: 10.1016/j.jstrokecerebrovasdis.2022.106716. Epub 2022 Aug 10.

Abstract

Objectives: To assess whether COVID-19 could be a concurrent factor in the genesis and/or worsening of stroke and to provide data on COVID-19 -associated stroke patients during the first pandemic wave and comparative data on COVID-19 negative stroke patients in the same period.

Materials and methods: This is a retrospective, observational, case-control, single centre study, carried out in a General Hospital in northern Italy. Sixty-three consecutive stroke patients were included, COVID-19-associated stroke was classified as cases and non COVID-19-associated stroke as controls.

Results: A total of 19/63 (28.8%) had a COVID-19-associated stroke, 11 /63 (17.5%) were haemorrhagic and 52/63 (82.5%) ischaemic. COVID-19-associated strokes were more severe (p-value 0.019) and had a higher risk of severe disability and/or death (OR 3.79, CI 95%: 1.21-11.93, p-value 0.19). The COVID-19-associated stroke patients with onset during hospitalization for COVID-19 had a more severe stroke than patients with COVID-19 onset during hospitalization for stroke (p-value 0.019).

Conclusion: Although no relationship was observed between the stroke aetiology and COVID-19, intriguingly, COVID-associated stroke turned out to be more severe and disabling. Hopefully, further studies will provide more data and help in the management of this emerging population.

Keywords: COVID-19; COVID-19-associated stroke; Case-control study; Large vessel occlusion; SARS-CoV-2.

Publication types

  • Observational Study

MeSH terms

  • COVID-19* / complications
  • COVID-19* / diagnosis
  • Case-Control Studies
  • Communicable Diseases* / complications
  • Humans
  • Pandemics
  • Retrospective Studies
  • SARS-CoV-2
  • Stroke* / complications
  • Stroke* / diagnosis
  • Stroke* / therapy